Cargando…
Signature laminar distributions of pathology in frontotemporal lobar degeneration
Frontotemporal lobar degeneration (FTLD) with either tau (FTLD-tau) or TDP-43 (FTLD-TDP) inclusions are distinct proteinopathies that frequently cause similar frontotemporal dementia (FTD) clinical syndromes. FTD syndromes often display macroscopic signatures of neurodegeneration at the level of reg...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858288/ https://www.ncbi.nlm.nih.gov/pubmed/34997851 http://dx.doi.org/10.1007/s00401-021-02402-3 |
_version_ | 1784654218588585984 |
---|---|
author | Ohm, Daniel T. Cousins, Katheryn A. Q. Xie, Sharon X. Peterson, Claire McMillan, Corey T. Massimo, Lauren Raskovsky, Katya Wolk, David A. Van Deerlin, Vivianna M. Elman, Lauren Spindler, Meredith Deik, Andres Trojanowski, John Q. Lee, Edward B. Grossman, Murray Irwin, David J. |
author_facet | Ohm, Daniel T. Cousins, Katheryn A. Q. Xie, Sharon X. Peterson, Claire McMillan, Corey T. Massimo, Lauren Raskovsky, Katya Wolk, David A. Van Deerlin, Vivianna M. Elman, Lauren Spindler, Meredith Deik, Andres Trojanowski, John Q. Lee, Edward B. Grossman, Murray Irwin, David J. |
author_sort | Ohm, Daniel T. |
collection | PubMed |
description | Frontotemporal lobar degeneration (FTLD) with either tau (FTLD-tau) or TDP-43 (FTLD-TDP) inclusions are distinct proteinopathies that frequently cause similar frontotemporal dementia (FTD) clinical syndromes. FTD syndromes often display macroscopic signatures of neurodegeneration at the level of regions and networks, but it is unclear if subregional laminar pathology display patterns unique to proteinopathy or clinical syndrome. We hypothesized that FTLD-tau and FTLD-TDP accumulate pathology in relatively distinct cortical layers independent of clinical syndrome, with greater involvement of lower layers in FTLD-tau. The current study examined 170 patients with either FTLD-tau (n = 73) or FTLD-TDP (n = 97) spanning dementia and motor phenotypes in the FTD spectrum. We digitally measured the percent area occupied by tau and TDP-43 pathology in upper layers (I–III), lower layers (IV–VI), and juxtacortical white matter (WM) from isocortical regions in both hemispheres where available. Linear mixed-effects models compared ratios of upper to lower layer pathology between FTLD groups and investigated relationships with regions, WM pathology, and global cognitive impairment while adjusting for demographics. We found lower ratios of layer pathology in FTLD-tau and higher ratios of layer pathology in FTLD-TDP, reflecting lower layer-predominant tau pathology and upper layer-predominant TDP-43 pathology, respectively (p < 0.001). FTLD-tau displayed lower ratios of layer pathology related to greater WM tau pathology (p = 0.002) and to earlier involved/severe pathology regions (p = 0.007). In contrast, FTLD-TDP displayed higher ratios of layer pathology not related to either WM pathology or regional severity. Greater cognitive impairment was associated with higher ratios of layer pathology in FTLD-tau (p = 0.018), but was not related to ratios of layer pathology in FTLD-TDP. Lower layer-predominant tau pathology and upper layer-predominant TDP-43 pathology are proteinopathy-specific, regardless of clinical syndromes or regional networks that define these syndromes. Thus, patterns of laminar change may provide a useful anatomical framework for investigating how degeneration of select cells and corresponding laminar circuits influence large-scale networks and clinical symptomology in FTLD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02402-3. |
format | Online Article Text |
id | pubmed-8858288 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-88582882022-02-23 Signature laminar distributions of pathology in frontotemporal lobar degeneration Ohm, Daniel T. Cousins, Katheryn A. Q. Xie, Sharon X. Peterson, Claire McMillan, Corey T. Massimo, Lauren Raskovsky, Katya Wolk, David A. Van Deerlin, Vivianna M. Elman, Lauren Spindler, Meredith Deik, Andres Trojanowski, John Q. Lee, Edward B. Grossman, Murray Irwin, David J. Acta Neuropathol Original Paper Frontotemporal lobar degeneration (FTLD) with either tau (FTLD-tau) or TDP-43 (FTLD-TDP) inclusions are distinct proteinopathies that frequently cause similar frontotemporal dementia (FTD) clinical syndromes. FTD syndromes often display macroscopic signatures of neurodegeneration at the level of regions and networks, but it is unclear if subregional laminar pathology display patterns unique to proteinopathy or clinical syndrome. We hypothesized that FTLD-tau and FTLD-TDP accumulate pathology in relatively distinct cortical layers independent of clinical syndrome, with greater involvement of lower layers in FTLD-tau. The current study examined 170 patients with either FTLD-tau (n = 73) or FTLD-TDP (n = 97) spanning dementia and motor phenotypes in the FTD spectrum. We digitally measured the percent area occupied by tau and TDP-43 pathology in upper layers (I–III), lower layers (IV–VI), and juxtacortical white matter (WM) from isocortical regions in both hemispheres where available. Linear mixed-effects models compared ratios of upper to lower layer pathology between FTLD groups and investigated relationships with regions, WM pathology, and global cognitive impairment while adjusting for demographics. We found lower ratios of layer pathology in FTLD-tau and higher ratios of layer pathology in FTLD-TDP, reflecting lower layer-predominant tau pathology and upper layer-predominant TDP-43 pathology, respectively (p < 0.001). FTLD-tau displayed lower ratios of layer pathology related to greater WM tau pathology (p = 0.002) and to earlier involved/severe pathology regions (p = 0.007). In contrast, FTLD-TDP displayed higher ratios of layer pathology not related to either WM pathology or regional severity. Greater cognitive impairment was associated with higher ratios of layer pathology in FTLD-tau (p = 0.018), but was not related to ratios of layer pathology in FTLD-TDP. Lower layer-predominant tau pathology and upper layer-predominant TDP-43 pathology are proteinopathy-specific, regardless of clinical syndromes or regional networks that define these syndromes. Thus, patterns of laminar change may provide a useful anatomical framework for investigating how degeneration of select cells and corresponding laminar circuits influence large-scale networks and clinical symptomology in FTLD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-021-02402-3. Springer Berlin Heidelberg 2022-01-08 2022 /pmc/articles/PMC8858288/ /pubmed/34997851 http://dx.doi.org/10.1007/s00401-021-02402-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Ohm, Daniel T. Cousins, Katheryn A. Q. Xie, Sharon X. Peterson, Claire McMillan, Corey T. Massimo, Lauren Raskovsky, Katya Wolk, David A. Van Deerlin, Vivianna M. Elman, Lauren Spindler, Meredith Deik, Andres Trojanowski, John Q. Lee, Edward B. Grossman, Murray Irwin, David J. Signature laminar distributions of pathology in frontotemporal lobar degeneration |
title | Signature laminar distributions of pathology in frontotemporal lobar degeneration |
title_full | Signature laminar distributions of pathology in frontotemporal lobar degeneration |
title_fullStr | Signature laminar distributions of pathology in frontotemporal lobar degeneration |
title_full_unstemmed | Signature laminar distributions of pathology in frontotemporal lobar degeneration |
title_short | Signature laminar distributions of pathology in frontotemporal lobar degeneration |
title_sort | signature laminar distributions of pathology in frontotemporal lobar degeneration |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858288/ https://www.ncbi.nlm.nih.gov/pubmed/34997851 http://dx.doi.org/10.1007/s00401-021-02402-3 |
work_keys_str_mv | AT ohmdanielt signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT cousinskatherynaq signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT xiesharonx signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT petersonclaire signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT mcmillancoreyt signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT massimolauren signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT raskovskykatya signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT wolkdavida signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT vandeerlinviviannam signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT elmanlauren signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT spindlermeredith signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT deikandres signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT trojanowskijohnq signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT leeedwardb signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT grossmanmurray signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration AT irwindavidj signaturelaminardistributionsofpathologyinfrontotemporallobardegeneration |